Samuel D. Banister

4.4k citations

99 papers · 3.5k indexed · 1 hit paper · h-index 33

Pharmacology top 0.2%
Toxicology top 0.02%
Cellular and Molecular Neuroscience top 1%
Molecular Biology top 10%
Clinical Psychology top 5%

Co-authors: Michael Kassiou Mark Connor Iain S. McGregor Michelle Glass Mitchell Longworth Richard C. Kevin Roy Gerona Corinne Beinat
Topics: Cannabis and Cannabinoid Research (57 papers)Forensic Toxicology and Drug Analysis (38 papers)Neurotransmitter Receptor Influence on Behavior (28 papers)
Cited by: Toxicology Pharmacology Cellular and Molecular Neuroscience
Journals: New England Journal of Medicine CellSHILAP Revista de lepidopterología
Partner nations: Australia United States New Zealand

In The Last Decade

Samuel D. Banister

99 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex

2019 318 citations Samuel D. Banister et al. profile →

Peers

Countries citing papers authored by Samuel D. Banister

Since Specialization

Citations

This map shows the geographic impact of Samuel D. Banister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel D. Banister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel D. Banister more than expected).

Fields of papers citing papers by Samuel D. Banister

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel D. Banister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel D. Banister. The network helps show where Samuel D. Banister may publish in the future.

Co-authorship network of co-authors of Samuel D. Banister

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel D. Banister. A scholar is included among the top collaborators of Samuel D. Banister based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel D. Banister. Samuel D. Banister is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA 2024 ·ACS Chemical Neuroscience ·(unknown),Axelle Timmerman,(unknown),Rochelle Boyd,(unknown),(unknown),Richard C. Kevin,David E. Hibbs,Samuel D. Banister,Elizabeth A. Cairns,Christophe P. Stove,(unknown)	2
2	Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB₂ receptor 2023 ·Pharmacology Research & Perspectives ·Monica Patel,Natasha L. Grimsey,Samuel D. Banister,David B. Finlay,Michelle Glass	7
3	Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA 2022 ·ACS Chemical Neuroscience ·(unknown),(unknown),(unknown),Rochelle Boyd,Felcia Lai,(unknown),(unknown),Roy Gerona,Matthew Connolly,Huiling Liu,David E. Hibbs,Elizabeth A. Cairns,Samuel D. Banister,Christophe P. Stove	6
4	Characterisation of AMB-FUBINACA metabolism and CB1-mediated activity of its acid metabolite 2022 ·Forensic Toxicology ·(unknown),David B. Finlay,Shuli Chen,Andrea J. Vernall,(unknown),Samuel D. Banister,Rhonda J. Rosengren,Michelle Glass	2
5	Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB₁ receptor activation assays: Part I—Synthesis, analytical characterization, and binding affinity for human CB₁ receptors 2021 ·Drug Testing and Analysis ·(unknown),Katharina Elisabeth Grafinger,Annelies Cannaert,(unknown),Jia Lin Luo,(unknown),Elizabeth A. Cairns,(unknown),Roy Gerona,Christophe P. Stove,Volker Auwärter,Samuel D. Banister	29
6	NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity? 2021 ·ACS Chemical Neuroscience ·(unknown),Elizabeth A. Cairns,Katharina Elisabeth Grafinger,Annelies Cannaert,(unknown),Shuli Chen,(unknown),(unknown),Felcia Lai,(unknown),Roy Gerona,(unknown),Richard C. Kevin,Iain S. McGregor,David E. Hibbs,Michelle Glass,Christophe P. Stove,Volker Auwärter,Samuel D. Banister	8
7	Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB₁ receptor activation assays—Part II: Structure activity relationship assessment via a β‐arrestin recruitment assay 2021 ·Drug Testing and Analysis ·Katharina Elisabeth Grafinger,Annelies Cannaert,(unknown),(unknown),Elizabeth A. Cairns,Samuel D. Banister,Volker Auwärter,Christophe P. Stove	32
8	Structure–activity relationships of valine, tert-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA 2021 ·RSC Medicinal Chemistry ·(unknown),Elizabeth A. Cairns,Richard C. Kevin,Felcia Lai,Katharina Elisabeth Grafinger,Shuli Chen,(unknown),(unknown),Rochelle Boyd,Lewis Martin,Iain S. McGregor,Roy Gerona,David E. Hibbs,Volker Auwärter,Michelle Glass,Christophe P. Stove,Samuel D. Banister	21
9	Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays 2021 ·Drug Testing and Analysis ·Katharina Elisabeth Grafinger,Marthe M. Vandeputte,Annelies Cannaert,(unknown),(unknown),Elizabeth A. Cairns,(unknown),(unknown),(unknown),Samuel D. Banister,Christophe P. Stove,Volker Auwärter	20
10	Synthesis and in Vitro Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA 2020 ·ACS Chemical Neuroscience ·Annelies Cannaert,(unknown),(unknown),Jia Lin Luo,(unknown),Richard C. Kevin,(unknown),Roy Gerona,Samuel D. Banister,Christophe P. Stove	78
11	In vitro determination of the efficacy of illicit synthetic cannabinoids at CB ₁ receptors 2019 ·British Journal of Pharmacology ·Shivani Sachdev,Kiran Vemuri,Samuel D. Banister,Mitchell Longworth,Michael Kassiou,Marina Santiago,Alexandros Makriyannis,Mark Connor	39
12	Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists 2019 ·Biochemical Pharmacology ·Elise Wouters,(unknown),Samuel D. Banister,Christophe P. Stove	69
13	Synthesis and pharmacology of new psychoactive substance 5F‐CUMYL‐P7AICA, a scaffold‐ hopping analog of synthetic cannabinoid receptor agonists 5F‐CUMYL‐PICA and 5F‐CUMYL‐PINACA 2018 ·Drug Testing and Analysis ·Samuel D. Banister,Axel Adams,Richard C. Kevin,Christa MacDonald,Michelle Glass,Rochelle Boyd,Mark Connor,Iain S. McGregor,Christopher Havel,Stephen Bright,Mireia Ventura,Cristina Gil,Monica J. Barratt,Roy Gerona	47
14	Effects of common anesthetic agents on [18F]flumazenil binding to the GABAA receptor 2016 ·EJNMMI Research ·Mikael Palner,Corinne Beinat,Samuel D. Banister,Francesca Zanderigo,Jun Hyung Park,Bin Shen,(unknown),Jae Ho Jung,Byung Chul Lee,Sang Eun Kim,Lawrence K. Fung,Frederick T. Chin	8
15	The Recent Development of α₇ Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases 2016 ·Current Pharmaceutical Design ·Corinne Beinat,Samuel D. Banister,Marco Herrera‐Barrera,Michael Kassiou	4
16	Recent Advances in the Development of Sigma-1 Receptor Ligands 2015 ·Australian Journal of Chemistry ·Madhura Manohar,Samuel D. Banister,Corinne Beinat,(unknown),Michael Kassiou	7
17	Structure–activity relationships of N-substituted 4-(trifluoromethoxy)benzamidines with affinity for GluN2B-containing NMDA receptors 2014 ·Bioorganic & Medicinal Chemistry Letters ·Corinne Beinat,Samuel D. Banister,(unknown),John Tsanaktsidis,Athanasios Metaxas,Albert D. Windhorst,Michael Kassiou	19
18	Altered proteostasis in aging and heat shock response in C. elegans revealed by analysis of the global and de novo synthesized proteome 2014 ·Cellular and Molecular Life Sciences ·(unknown),(unknown),Hong Lam,Yee Lian Chew,Samuel D. Banister,Xiaomin Song,Thiri Zaw,Michael Kassiou,Jürgen Götz,Hannah Nicholas	61
19	Bioisosteric Fluorine in the Clandestine Design of Synthetic Cannabinoids 2014 ·Australian Journal of Chemistry ·Shane M. Wilkinson,Samuel D. Banister,Michael Kassiou	31
20	N-substituted 8-aminopentacyclo[5.4.0.02,6.03,10.05,9]undecanes as σ receptor ligands with potential neuroprotective effects 2013 ·Bioorganic & Medicinal Chemistry ·Samuel D. Banister,(unknown),Melissa L. Barron,Eryn L. Werry,Michael Kassiou	17

About Samuel D. Banister

Samuel D. Banister is a scholar working on Toxicology, Pharmacology and Cellular and Molecular Neuroscience, having authored 99 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (57 papers), Forensic Toxicology and Drug Analysis (38 papers) and Neurotransmitter Receptor Influence on Behavior (28 papers). The work is most often cited by research in Toxicology (1.6k citations), Pharmacology (2.0k citations) and Cellular and Molecular Neuroscience (1.4k citations). Samuel D. Banister has collaborated with scholars based in Australia, United States and New Zealand. Frequent co-authors include Michael Kassiou, Mark Connor, Iain S. McGregor, Michelle Glass, Mitchell Longworth, Richard C. Kevin, Roy Gerona, Corinne Beinat, Jordyn Stuart and Shane M. Wilkinson. Their work appears in journals such as New England Journal of Medicine, Cell and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact